A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience
2020
Critical Care
Preserved Fulltext
